TG Therapeutics Inc (STU:NKB2)
€ 16.066 0.548 (3.53%) Market Cap: 2.49 Bil Enterprise Value: 2.39 Bil PE Ratio: 78.73 PB Ratio: 16.72 GF Score: 72/100

TG Therapeutics Inc (STU:NKB2) Transcripts

  • 1